Not independent
Tenure on this board
8.2 yrs
Also a director at
4D Molecular Therapeutics Inc (FDMT)
Meeting calendar
ORIC · Annual meeting · Thursday, June 18, 2026
Oric Pharmaceuticals Inc
2 nominees · 5 ballot items.
Election of two Class III directors; Ratification of KPMG LLP as independent auditors; Approval of the 2020 Equity Incentive Plan as amended and restated; Advisory vote to approve named executive officer compensation (say-on-pay); Advisory vote on frequency of future say-on-pay votes.
Market cap
$1.1B
1Y TSR
-8.5%
Board grade
C-
Record date
Apr 20, 2026
Filing
DEF 14A
Meeting concluded · Jun 18, 2026
Follow how the vote landed and what changed on Oric Pharmaceuticals Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot5
- 1
Election of Directors
ManagementBoard: FORElect two Class III directors (Jacob M. Chacko, M.D. and Mardi C. Dier) to serve until the 2029 annual meeting.
- 2
Ratification of Appointment of Independent Registered Public Accounting Firm
ManagementBoard: FORRatify KPMG LLP as the Company’s independent registered public accounting firm for fiscal year ending December 31, 2026.
- 3
Approval of the ORIC Pharmaceuticals, Inc. 2020 Equity Incentive Plan, as Amended and Restated
ManagementBoard: FORApprove amendments to the 2020 Plan to (i) modify the Evergreen provision reducing annual increase from 5% to 4% and removing numerical cap, (ii) specify an ISO cap of 10,000,000 shares, and (iii) eliminate administrator authority to implement an Exchange Program (repricing/exchange of awards) without stockholder approval.
- 4
Advisory Vote to Approve Named Executive Officer Compensation (Say-on-Pay
ManagementBoard: FORNon-binding, advisory approval of the compensation of the named executive officers as disclosed in the proxy statement.
- 5
Advisory Vote on Frequency of Future Say-on-Pay Votes
ManagementBoard: FORNon-binding advisory vote to select frequency (every 1, 2, or 3 years) for future advisory votes on named executive officer compensation; board recommends every year.
Director elections
Nominees on the ballot2
Independent
Tenure on this board
6.4 yrs
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Nextech Invest, Ltd. | 6.9% | 7,162,637 | $91M |
| 2 | EcoR1 Capital, LLC | 6.5% | 6,728,116 | $85M |
| 3 | VIKING GLOBAL INVESTORS LP | 5.6% | 5,824,533 | $74M |
| 4 | PRICE T ROWE ASSOCIATES INC /MD/ | 5.1% | 5,285,130 | $67M |
| 5 | PFIZER INC | 4.6% | 4,780,401 | $58M |
| 6 | SR ONE CAPITAL MANAGEMENT, LP | 4.4% | 4,514,929 | $58M |
| 7 | Venrock Adviser, LLC | 4.2% | 4,319,765 | $55M |
| 8 | NEA Management Company, LLC | 4.0% | 4,118,621 | $52M |
| 9 | ALKEON CAPITAL MANAGEMENT LLC | 3.6% | 3,751,818 | $48M |
| 10 | STATE STREET CORP | 3.6% | 3,702,196 | $47M |
Peers
Nearest market capOther Healthcare sector meetings6
Upcoming shareholder meetings at Oric Pharmaceuticals Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Avanos Medical IncAVNS
Special meeting·Jul 22, 2026·$1.2B
Aura Biosciences IncAURA
Special meeting·Aug 5, 2026·$712M
Anaptysbio IncANAB
Annual meeting·Aug 11, 2026·$1.6B
Trulieve Cannabis CorpTRLV
Special meeting·Aug 5, 2026·$1.6B
Indaptus Therapeutics IncINDP
Annual meeting·Aug 10, 2026·$287M
Seer IncSEER
Annual meeting·Jul 28, 2026·$119M
Reference
Frequently asked questions
- When is the Oric Pharmaceuticals Inc 2026 annual meeting?
- Oric Pharmaceuticals Inc (ORIC) holds its 2026 annual shareholder meeting on Thursday, June 18, 2026.
- What is the record date for the Oric Pharmaceuticals Inc 2026 meeting?
- The record date for the Oric Pharmaceuticals Inc 2026 meeting is Monday, April 20, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Oric Pharmaceuticals Inc's 2026 meeting?
- The board is presenting 2 director nominees at the Oric Pharmaceuticals Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Oric Pharmaceuticals Inc 2026 meeting?
- Shareholders will vote on 5 proposals at the Oric Pharmaceuticals Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.